MONTEREY, Calif., July 29, 2026
Elevation Spine has received U.S. Food and Drug Administration (FDA) 510(k) Clearance for Saber-C® AVIA™, its latest anterior cervical fixation system designed to enhance anterior cervical discectomy and fusion (ACDF) procedures. The newly cleared system expands the company’s innovative Saber platform by integrating a porous 3D-printed titanium interbody with both spike and screw fixation options, providing surgeons with greater flexibility while maintaining the biomechanical stability traditionally associated with anterior cervical plating. Engineered as a zero-profile cervical fusion construct, Saber-C AVIA features a streamlined surgical workflow, refined instrumentation, and an implant architecture specifically designed to support bone ingrowth. The FDA clearance marks another significant milestone for Elevation Spine as it continues advancing spinal surgery technologies that simplify procedures, improve implant performance, and enhance patient outcomes. Available immediately across the United States, the new system strengthens the company’s position in the rapidly evolving spinal medical device market by delivering next-generation fixation technology tailored to the needs of modern spine surgeons.
FDA Clearance Expands the Saber Platform
The FDA 510(k) clearance of Saber-C AVIA™ represents a major advancement in cervical spine surgery technology. Built specifically for ACDF procedures, the system combines integrated fixation with a zero-profile implant design, reducing the need for traditional anterior cervical plates while preserving the stability surgeons require during spinal fusion procedures. The platform introduces multiple refinements based on direct surgeon feedback, including a slimmer surgical workflow, redesigned spike delivery instruments, and newly developed low-profile screw insertion tools that improve precision during implantation. Every Saber-C AVIA system is supplied with both spike and screw instrumentation in a single surgical tray, allowing physicians to select the most appropriate fixation option for individual patient anatomy without requiring additional instrument sets. This comprehensive design increases procedural efficiency while supporting a broad range of cervical fusion cases in operating rooms.
Porous 3D-Printed Titanium Implant Supports Bone Integration
One of the defining innovations of Saber-C AVIA™ is its advanced porous 3D-printed titanium interbody implant, engineered with a 55% porosity lattice architecture designed to closely mimic the structure of natural trabecular bone. According to preclinical research, the porous architecture is associated with bone ingrowth, supporting long-term implant stability and successful spinal fusion. The implant is available in both 6-degree lordotic and 12-degree hyperlordotic configurations, allowing surgeons to restore cervical alignment while accommodating varying patient anatomies and surgical objectives. A large central graft window further supports bone graft placement, encouraging biological fusion across the treated spinal segment. By combining advanced implant engineering with integrated fixation technology, Elevation Spine has developed a solution that addresses both mechanical stability and biological healing, two essential factors influencing successful cervical spine fusion outcomes.
Innovation Driven by Surgeon Collaboration
Elevation Spine emphasized that the development of Saber-C AVIA™ was guided by extensive collaboration with its growing community of spine surgeons. Feedback from clinical users helped shape refinements across the implant system and surgical instrumentation, enabling the company to rapidly implement practical improvements that enhance both workflow efficiency and procedural confidence. As a specialized spinal medical device developer, Elevation Spine continues focusing on technologies that simplify surgery while improving patient care through meaningful innovation. The FDA clearance reinforces the company’s commitment to delivering integrated fixation systems that combine advanced biomaterials, precision instrumentation, and minimally invasive design principles. With immediate commercial availability throughout the United States, Saber-C AVIA™ is expected to expand surgical options for physicians performing anterior cervical discectomy and fusion, while strengthening Elevation Spine’s growing portfolio of next-generation spinal implants designed to improve outcomes for patients requiring cervical spine stabilization and reconstruction.
Source: Elevation Spine press release



